Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
54.37 USD | -5.61% | -10.17% | +36.85% |
08/05 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
08/05 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Official Publications